Lemaitre Vascular Inc (LMAT) Company Profile & Statistics

Lemaitre Vascular Inc
LMAT
(Nasdaq - US)
N/A
64.13
-0.10 (-0.16%)
in:usd•As of: Apr 24, 2024 15:59 UTC -4
Open
63.62
High
64.51
Low
63.50

About Lemaitre Vascular Inc

CEO

George W. LeMaitre

Headquarters

63 second avenue

burlington, ma 01803, united states

Auditor

GRANT THORNTON LLP

Employees

630

Share Holders

144

Website

www.lemaitre.com

Industry

medical specialties

Sector

health technology

Company Overview

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.

Lemaitre Vascular Inc Statistics

Valuation Measures

Market Capitalization ²	1.44B
Enterprise Value	1.42B
Enterprise Value/EBITDA (ttm)	30.62
Price to Earnings Ratio (ttm)	46.50
Price to Book (mrq)	4.69
Price to Sales (ttm)	7.28
Price to Cash (ytd)	35.15

Profitability

Gross Margin (ttm)	65.67%
Operating Margin (ttm)	15.63%
Profit Margin (ttm)	15.53%
Return on Equity (ttm)	10.57%
Return on Invested Capital (ttm)	10.50%
Return on Assets (ttm)	9.15%

Income Statement

Revenue (ttm)	193.48M
Revenue Per Share (ttm)	8.66
Gross Profit (ttm)	127.05M
EBITDA (ttm)³	46.23M
Net Income Avi to Common (ttm)	30.10M
Diluted EPS (ttm)	1.34

Share Statistics

Beta (5Y Monthly)	0.87
52-Week Change	17.98%
S&P500 52-Week Change	22.59%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	22.34M
Dividend Yield	1.02%
Float ⁴	20.02M
% Held by Insiders	10.79%
% Held by Institutions	84.64%

Balance Sheet

Total Cash (mrq)	105.07M
Total Cash Per Share (mrq)	4.70
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.51%
Quick Ratio (mrq)	4.57%
Book Value Per Share (mrq)	13.34

Cash Flow

Operating Cash Flow Per Share (ytd)	1.64
Free Cash Flow (ytd)	29.49M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Lemaitre Vascular Inc

Trade With A Regulated Broker